Reduced levels of VDAC1 and Aβ may maintain normal mitochondrial pore opening and pore closure, ultimately leading to normal mitochondrial function, allowing mitochondria to supply ATP to nerve terminals and boosting synaptic and cognitive function in AD (Manczak and Reddy, 2012b). Here, VDAC1 is linked to Alzheimer disease.